(Reuters) – U.S. drugmaker Merck & Co Inc said on Monday the European Union’s drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults. Read full story
(Reuters) – U.S. drugmaker Merck & Co Inc said on Monday the European Union’s drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults. Read full story